Pancreatic Polypeptide as a Modulator of Amylin- Induced Satiety in Healthy Humans
Recruiting
N/A
Interventional Study
Obesity & Overweight
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 65
- Sex
- Male
- Study type
- Interventional
- Purpose
- Basic Science
- Participants needed
- 18 (estimated)
- Sponsor
- University Hospital, Gentofte, Copenhagen · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The two pancreatic hormones amylin and pancreatic polypeptide (PP) has been linked to satiety and energy metabolism. The goal of this this study is to determine the separate and combined effects of the two hormones on food intake and other exploratory endpoints related to metabolism in healthy humans. The aim of this study is to investigate the interaction between the hormones and obtain insight i…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Male
* Age between 18 and 65 years at the time of inclusion
* Body mass index 18-27 kg/m2
* Fat percentage \< 20%
* Informed oral and written consent
Exclusion Criteria:
* Anaemia (haemoglobin below normal range)
* History of hepatobiliary and/or gastrointestinal disorder(s)…
Contacts